Literature DB >> 16142409

XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.

Joachim Schneider1, Vera Classen, Ulrike Bernges, Monika Philipp.   

Abstract

DNA repair plays a critical role in protecting the genome of the cell from carcinogens or ionising radiation. Reduced DNA-repair capacity can increase susceptibility to occupational-induced cancer. Three coding polymorphisms at codons 194, 280, and 399 in X-ray cross complementing group 1 (XRCC1) DNA-repair gene have been identified, and it is possible that these polymorphisms may affect DNA- repair capacity and thus modulate cancer susceptibility. In the current German study, we investigated the role of XRCC1-polymorphisms as a genetic modifier of risk for individuals with lung cancer as susceptible genotypes, especially in relation to tobacco smoking. Three polymorphisms; XRCC1 Arg194Trp, XRCC1 Arg280His and XRCC1 Arg399Gln, were determined by real-time PCR analysis in 446 lung cancer patients and 622 controls. The observed allele frequencies in the population were within the range described for Caucasians. Multivariate analyses of lung cancer patients who carried at least one mutant variant allele of XRCC1 Arg194Trp (OR=1.03; 95%-CI: 0.66-1.61), XRCC1 Arg280His (OR=0.95; 95%-CI: 0.57-1.60), or XRCC1 Arg399Gln (OR=0.99 CI: 0.73-1.34), did not show any elevated risks. When analysed by histology, no individual subtype of lung cancer was significantly associated with the polymorphisms. Lung cancer risk rose significantly with higher cumulative cigarette consumption. Stratified analysis between tobacco smoking and variant genotypes revealed increasing risks for heavy smokers (>60 pack-years), with the presence of at least one copy of the XRCC1 Arg194Trp variant allele (OR=79.29; 95%-CI: 8.53-737.04) and the XRCC1 Arg399Gln (OR=61.87; 95%-CI: 15.65-244.67). By analysing the interaction between tobacco smoking and the genotypes, combined smoking and having the susceptible genotypes did not show a joint effect. In this study, the XRCC1 Arg194Trp, XRCC1 Arg280His, and XRCC1 Arg399Gln-polymorphisms, had no relevant modifying effect on lung cancer risk and cumulative smoking dose.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142409

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  15 in total

1.  XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies.

Authors:  Liping Dai; Fujiao Duan; Peng Wang; Chunhua Song; Kaijuan Wang; Jianying Zhang
Journal:  Mol Biol Rep       Date:  2012-06-23       Impact factor: 2.316

2.  Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis.

Authors:  Wenlong Zhai; Ruo Feng; Haiyu Wang; Yadong Wang
Journal:  Tumour Biol       Date:  2015-04-03

3.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

4.  Note of clarification of data in the paper entitled no association between XRCC1 gene Arg194Trp polymorphism and risk of lung cancer: evidence based on an updated cumulative meta-analysis.

Authors:  Haiyan Yang; Fuye Shao; Haiyu Wang; Yadong Wang
Journal:  Tumour Biol       Date:  2015-03-14

5.  Clinical outcome of cisplatin-based chemotherapy is associated with the polymorphisms of GSTP1 and XRCC1 in advanced non-small cell lung cancer patients.

Authors:  J-H Deng; J Deng; D-H Shi; X-N Ouyang; P-G Niu
Journal:  Clin Transl Oncol       Date:  2015-06-02       Impact factor: 3.405

Review 6.  Smoking and selected DNA repair gene polymorphisms in controls: systematic review and meta-analysis.

Authors:  M Elizabeth Hodgson; Charles Poole; Andrew F Olshan; Kari E North; Donglin Zeng; Robert C Millikan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-08       Impact factor: 4.254

7.  Lung cancer risk and genetic polymorphisms in DNA repair pathways: a meta-analysis.

Authors:  Chikako Kiyohara; Koichi Takayama; Yoichi Nakanishi
Journal:  J Nucleic Acids       Date:  2010-10-14

8.  Polymorphisms in the vitamin D receptor gene and the lung cancer risk.

Authors:  Yingjv Fu; Junrui Li; Yuanyue Zhang
Journal:  Tumour Biol       Date:  2013-09-26

9.  XRCC1 codon 280 polymorphism and susceptibility to lung cancer: a meta-analysis of the literatures.

Authors:  Qin-xiang Guo; Wei-hua Yang; Jin-fang Zhai; Fu-cai Han; Chun-yan Wang
Journal:  Tumour Biol       Date:  2013-06-04

10.  X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis.

Authors:  Ji-Ying Wang; Yong Cai
Journal:  Tumour Biol       Date:  2013-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.